FTSE 100 Rises Over 0.5%

U.K. stocks, represented by the FTSE 100, advanced 0.51% to 9,261.35 on Friday, as investors largely disregarded new U.S. tariffs announced by President Trump on imported branded pharmaceuticals (100%) and heavy-duty trucks (25%), while anticipating upcoming U.S. PCE data.

Analysis

The U.K. market demonstrated notable resilience, with the FTSE 100 index advancing 0.51% to 9,261.35 despite the announcement of new U.S. tariffs. Investors appear to be largely discounting the impact of a 100% levy on branded pharmaceuticals and a 25% tariff on heavy-duty trucks, instead focusing on forthcoming U.S. PCE data as a more significant market driver. Sector performance was divergent; strength was evident in hospitality with Intercontinental Hotels Group gaining over 2.5%, and in financials with Natwest Group up 2.1%. Intriguingly, Hikma Pharmaceuticals rose 2.3% in defiance of the sector-specific tariff news, suggesting the market perceives its exposure as limited. Conversely, the materials and mining sectors faced headwinds, with Metlen Energy & Metals and Rio Tinto declining by over 2% and 1.7% respectively, signaling weakness in commodity-linked equities. The broad-based gains across various other large-cap names like Barclays and Smith & Nephew underscore a moderately positive sentiment, though the underperformance of the materials sector warrants attention.

Key Decisions for Investors

• The market's muted reaction to the tariff news suggests investors should prioritize the upcoming U.S. PCE data as a more critical indicator for near-term market direction.
• The divergence between strong performers like Intercontinental Hotels and financials versus weakness in miners like Rio Tinto indicates a potential sector rotation; review portfolio exposure to materials and resources.
• The counterintuitive strength in Hikma Pharmaceuticals, despite targeted pharma tariffs, merits further due diligence to assess its specific insulation from this risk, which could represent a mispriced opportunity.
• Given the broad market advance, maintain a constructive stance on U.K. equities but monitor the widening performance gap between cyclical sectors for signs of shifting risk appetite.